Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Raskob, Gary

One or more keywords matched the following items that are connected to Raskob, Gary

Item Type	Name
Concept	Factor Xa Inhibitors
Concept	Factor Xa
Academic Article	Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
Academic Article	Oral rivaroxaban for symptomatic venous thromboembolism.
Academic Article	Apixaban for extended treatment of venous thromboembolism.
Academic Article	Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
Academic Article	Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
Academic Article	Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Academic Article	Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
Academic Article	Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Academic Article	Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
Academic Article	Extended prophylaxis of venous thromboembolism with idraparinux.
Academic Article	Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Academic Article	Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Academic Article	Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Academic Article	Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Academic Article	The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Academic Article	Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
Academic Article	Edoxaban for Cancer-Associated Venous Thromboembolism.
Academic Article	Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Academic Article	Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Academic Article	Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
Academic Article	Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
Academic Article	Oral apixaban for the treatment of acute venous thromboembolism.
Academic Article	Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Academic Article	Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Academic Article	A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Academic Article	A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Academic Article	Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
Academic Article	Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Academic Article	Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
Academic Article	Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Academic Article	Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
Academic Article	The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
Academic Article	Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Academic Article	Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
Academic Article	The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Academic Article	Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
Academic Article	Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
Academic Article	Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
Academic Article	Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
Academic Article	Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.

Search Criteria

Factor Xa